Tai Chi Prehabilitation for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Prostate Cancer+1 More
Tai Chi Prehabilitation - Other
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial tests the feasibility of using an online Tai Chi intervention to help reduce anxiety and improve physical function for prostate cancer patients before and after surgery.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

6 Primary · 7 Secondary · Reporting Duration: 5 months

5 months
Brief Pain Inventory (BPI)
Expanded Prostate Cancer Index Composite (EPIC)
General Anxiety Disorder 7-item Scale (GAD-7)
Patient Health Questionnaire (PHQ-9)
Physical function
Pittsburgh Sleep Quality Inventory (PSQI)
Short Form-36 (SF-36)
8 weeks
Adherence to intervention
Adverse events
Intervention barriers and facilitators
Intervention uptake ratio
Participant recruitment rate
Reasons for withdrawal

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Tai Chi Prehabilitation
1 of 2
Usual Care
1 of 2

Experimental Treatment

Non-Treatment Group

40 Total Participants · 2 Treatment Groups

Primary Treatment: Tai Chi Prehabilitation · Has Placebo Group · N/A

Tai Chi Prehabilitation
Other
Experimental Group · 1 Intervention: Tai Chi Prehabilitation · Intervention Types: Other
Usual Care
Other
PlaceboComparator Group · 1 Intervention: Usual care · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 months

Who is running the clinical trial?

AHS Cancer Control AlbertaLead Sponsor
176 Previous Clinical Trials
35,940 Total Patients Enrolled
13 Trials studying Prostate Cancer
1,677 Patients Enrolled for Prostate Cancer
Canadian Cancer Society (CCS)OTHER
70 Previous Clinical Trials
30,898 Total Patients Enrolled
6 Trials studying Prostate Cancer
1,617 Patients Enrolled for Prostate Cancer
Lin Yang, PhDPrincipal InvestigatorAlberta Health services

Eligibility Criteria

Age 18+ · Male Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 3rd, 2021

Last Reviewed: November 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.